Drug Profile
Research programme: enterovirus A vaccine - Adimmune Corporation
Alternative Names: Enterovirus A infection vaccine - Adimmune Corporation; EV71 vaccine - Adimmune CorporationLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Adimmune Corporation
- Class Enterovirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Enterovirus A infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Enterovirus A infections(Prevention) in Taiwan
- 05 Oct 2012 Preclinical trials in Enterovirus A infections (prevention) in Taiwan (unspecified route)